Rare mendelian primary immunodeficiency diseases associated with impaired NF-κB signaling

M. Paciolla, A. Pescatore, M. I. Conte, E. Esposito, M. Incoronato, M. B. Lioi, F. Fusco, M. V. Ursini

Research output: Contribution to journalArticlepeer-review


Mendelian primary immunodeficiency diseases (MPIDs) are rare disorders affecting distinct constituents of the innate and adaptive immune system. Although they are genetically heterogeneous, a substantial group of MPIDs is due to mutations in genes affecting the nuclear factor-κB (NF-κB) transcription pathway, essential for cell proliferation and cell survival and involved in innate immunity and inflammation. Many of these genes encode for crucial regulatory components of the NF-κB pathway and their mutations are associated with immunological and developmental signs somehow overlapping in patients with MPIDs. At present, nine different MPIDs listed in the online mendelian inheritance in man (OMIM) are caused by mutations in at least nine different genes strictly involved in the NF-κB pathway that result in defects in immune responses. Here we report on the distinct function of each causative gene, on the impaired NF-κB step and more in general on the molecular mechanisms underlining the pathogenesis of the disease. Overall, the MPIDs affecting the NF-κB signalosome require a careful integrated diagnosis and appropriate genetic tests to be molecularly identified. Their discovery at an ever-increasing rate will help establish a common therapeutic strategy for a subclass of immunodeficient patients.

Original languageEnglish
Pages (from-to)239-246
Number of pages8
JournalGenes and Immunity
Issue number4
Publication statusPublished - Jun 6 2015

ASJC Scopus subject areas

  • Genetics(clinical)
  • Immunology
  • Genetics


Dive into the research topics of 'Rare mendelian primary immunodeficiency diseases associated with impaired NF-κB signaling'. Together they form a unique fingerprint.

Cite this